Customer Reviews
"Dead-Cert® technology saved a valuable hybridoma that had been stored in liquid nitrogen since 1987 and had undergone partial, accidental thawing 4-5 years later. Viability on all vials resuscitated was less than 20% and even with cleaning up by density gradient centrifugation and plating out on macrophage feeders and extra supplements they failed to re-establish the line. Dead-Cert® Nanoparticles were used to rescue the line from one of the last remaining vials allowing new cell bank stocks to be established for this very valuable hybridoma and monoclonal antibody."
Dr David Deane and Professor Gary Entrican, Moredun Research Institute
"I was attempting to expand some T-cell clones that had been frozen down for over 5 years and only very low numbers of cells were available. Dead-Cert® Nanoparticles worked well in making it possible to successfully resuscitate the cells and I look forward to using this technology for future resuscitation of valuable, related clones."
Dr Wendy Pickford, University of Aberdeen
"My laboratory has been using the Dead-Cert®-imab6 for the past several months and we are quite happy with its performance in our assays. We find this antibody to be very specific for phosphatidylserine recognition and highly effective in blocking phosphatidylserine dependent biological events. We find this to be better than annexin V in multiple situations, where the calcium buffer necessary for binding of annexin V interferes with our studies – but the Dead-Cert® binding occurs without the need for extra calcium in the buffer and does not unnecessarily alter the biological processes."
Professor Kodi Ravichandran, University of Virginia